Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are able to understand the study and are willing to sign a consent form approved by an ethics board.
- You are over 55 years old at the time of joining the study.
- You have been newly diagnosed with a suspected cancer of the ovaries, the lining of the abdomen (peritoneum), or the fallopian tubes at an advanced stage (Stage II–IV), OR a newly diagnosed suspected cancer of the uterus (endometrial cancer) at an advanced stage (Stage II–IV).
- You are planned to receive 3 or 4 cycles of chemotherapy before surgery (called neoadjuvant chemotherapy), with surgery planned afterwards to remove as much cancer as possible.
- You are able to read, understand, and write in English.
- You are able to understand and follow the study procedures for the full length of the study, as decided by the doctor running the trial.
Who may not be able to join:
- You have a history of cancer that has spread to the brain.
- You have a history of serious mental health conditions that required a hospital stay in the last 3 months, or a history of brain injury, stroke, or dementia.
- You are currently taking certain medications that affect the brain, including anti-amyloid drugs, cholinesterase inhibitors, or glutamate regulators (confirm with trial site if you are unsure whether your medications fall into these categories).
- You have a vision problem that would make it difficult to complete the study assessments, as decided by the doctor running the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anna Kuan-Celarier, MD, Wake Forest University Health Sciences
Phone: 336-713-5879
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in electronic frailty index (eFI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.